AB Science S.A. funding
AB Science S.A., a biotechnology company based in Paris, France, filed a Form D with the SEC on July 17, 2026 and reported $2M raised. It filed 2 new offerings in this period, totaling $5M.
Amount raised$2M
Offering size$2M
Filed with the SECJuly 17, 2026
First saleJuly 3, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationParis, France
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far2
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 17
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| July 17, 2026 | $2M | $2M | Equity, Options or warrants, Security to be acquired on exercise |
| May 18, 2026 | $3M | $3M | Equity, Options or warrants, Security to be acquired on exercise |
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology